Cargando…

Icosapent ethyl for the treatment of severe hypertriglyceridemia

Hypertriglyceridemia is a highly prevalent lipid abnormality and it is associated with atherosclerosis, with a growing body of evidence linking elevated triglycerides (TGs) with cardiovascular disease. The current major omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA)/docosahexaenoic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fares, Hassan, Lavie, Carl J, DiNicolantonio, James J, O’Keefe, James H, Milani, Richard V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077874/ https://www.ncbi.nlm.nih.gov/pubmed/25028554 http://dx.doi.org/10.2147/TCRM.S36983

Ejemplares similares

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
por: Fares, Hassan, et al.
Publicado: (2016)

The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk
por: Khan, Muhammad Shoaib, et al.
Publicado: (2021)

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
por: Weintraub, William S., et al.
Publicado: (2022)

The Importance of Marine Omega-3s for Brain Development and the Prevention and Treatment of Behavior, Mood, and Other Brain Disorders
por: DiNicolantonio, James J., et al.
Publicado: (2020)

Markedly increased intake of refined carbohydrates and sugar is associated with the rise of coronary heart disease and diabetes among the Alaskan Inuit
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Low-grade metabolic acidosis as a driver of chronic disease: a 21st century public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Magnesium for the prevention and treatment of cardiovascular disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Icosapent Ethyl (Vascepa®) for the Treatment of Acute, Severe Pancreatitis
por: Berger, Amnon A, et al.
Publicado: (2020)

Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014)

The introduction of refined carbohydrates in the Alaskan Inland Inuit diet may have led to an increase in dental caries, hypertension and atherosclerosis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Effects of dietary fats on blood lipids: a review of direct comparison trials
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Importance of maintaining a low omega–6/omega–3 ratio for reducing inflammation
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Low-grade metabolic acidosis as a driver of insulin resistance
por: DiNicolantonio, James J, et al.
Publicado: (2021)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Lorcaserin for the treatment of obesity? A closer look at its side effects
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
por: DiNicolantonio, James J, et al.
Publicado: (2015)

The health benefits of vitamin K
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Copper deficiency may be a leading cause of ischaemic heart disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Icosapent ethyl: scientific and legal controversies
por: Curfman, Gregory, et al.
Publicado: (2021)

Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Coenzyme Q10 for the treatment of heart failure: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Pentoxifylline for vascular health: a brief review of the literature
por: McCarty, Mark F, et al.
Publicado: (2016)

Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015)

Decreased magnesium status may mediate the increased cardiovascular risk associated with calcium supplementation
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications
por: DiNicolantonio, James J, et al.
Publicado: (2018)

Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Nutraceutical Prevention of Diabetic Complications—Focus on Dicarbonyl and Oxidative Stress
por: McCarty, Mark F., et al.
Publicado: (2022)

Nutraceutical activation of Sirt1: a review
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Clinical results and mechanism of action of icosapent ethyl
por: Borghi, Claudio, et al.
Publicado: (2023)

A Head‐to‐Head Comparison of a Free Fatty Acid Formulation of Omega‐3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE‐IT Study
por: Maki, Kevin C., et al.
Publicado: (2022)

Dietary fats, blood pressure and artery health
por: DiNicolantonio, James J, et al.
Publicado: (2019)

Importance of maintaining a low omega-6/omega-3 ratio for reducing platelet aggregation, coagulation and thrombosis
por: DiNicolantonio, James J, et al.
Publicado: (2019)

The benefits of marine omega-3s for preventing arrhythmias
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
por: Parhofer, Klaus G, et al.
Publicado: (2020)

An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
por: Elagizi, Andrew, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34mcj2lpoe4hp85fr8cgqpftlu